XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 24,168 $ 37,099
Restricted cash 79 308
Accounts receivable and unbilled, net (includes $0.8 million and $2.3 million with related parties at September 30, 2017 and December 31, 2016, respectively) 74,708 79,767
Prepaid expenses and other current assets 18,074 16,074
Total current assets 117,029 133,248
Property and equipment, net 45,903 43,805
Goodwill 660,981 660,981
Intangible assets, net 108,234 136,071
Deferred income taxes 11,115 97
Other assets 5,614 4,903
Total assets 948,876 979,105
Current liabilities:    
Accounts payable 9,972 10,911
Accrued expenses 20,085 24,417
Pre-funded study costs (includes $1.5 million and $3.9 million with related parties at September 30, 2017 and December 31, 2016, respectively) 53,246 51,948
Advanced billings (includes $2.7 million and $7.6 million with related parties at September 30, 2017 and December 31, 2016, respectively) 68,341 65,668
Current portion of long-term debt 15,469 12,375
Other current liabilities 5,250 3,284
Total current liabilities 172,363 168,603
Long-term debt, net, less current portion 169,152 151,267
Deemed landlord liability, less current portion 27,104 28,527
Deferred income tax liability 513 12,030
Deferred credit 20,956  
Other long-term liabilities 8,538 7,968
Total liabilities 398,626 368,395
Commitments and contingencies (see Note 11)
Shareholders’ equity:    
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively
Common stock - $0.01 par-value; 250,000,000 shares authorized at September 30, 2017 and December 31, 2016, respectively; 37,403,764 and 40,662,856 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 375 407
Additional paid-in capital 628,558 623,629
Accumulated deficit (77,420) (9,584)
Accumulated other comprehensive loss (1,263) (3,742)
Total shareholders’ equity 550,250 610,710
Total liabilities and shareholders’ equity $ 948,876 $ 979,105